SCHEMBL1490501

SCHEMBL1490501

COc1c(F)cc(F)c(C(=O)Nc2csc(-c3cccc(Cl)c3)c2C(=O)O)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 1/20 0.39
▸ TAS1R1 Q7RTX1 1/20 0.39
▸ TAS1R2 Q8TE23 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ DHODH Q02127 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ PKM P14618 1/20 0.37
▸ ACLY P53396 1/20 0.37
▸ ANO1 Q5XXA6 1/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ PTGFR P43088 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ NPC1 O15118 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490412 0.90 POLB (0.38) TAS1R3TAS1R1TAS1R2POLBMAPT
SCHEMBL1490162 0.90 DHODH (0.40) TAS1R3TAS1R1TAS1R2POLBMAPT
SCHEMBL1490335 0.90 DHODH (0.38) TAS1R3TAS1R1TAS1R2POLBDHODH
SCHEMBL1490216 0.90 KMT2A (0.41) TAS1R3TAS1R1TAS1R2POLBDHODH
SCHEMBL1490408 0.89 ANO1 (0.42) TAS1R3TAS1R1TAS1R2POLBKDM4E
SCHEMBL1490343 0.89 POLB (0.43) POLBMAPTKDM4EDHODHMEN1
SCHEMBL1490748 0.89 PTGFR (0.43) TAS1R3TAS1R1TAS1R2POLBDHODH
SCHEMBL1490515 0.86 DHODH (0.40) TAS1R3TAS1R1TAS1R2POLBMAPT
SCHEMBL1490356 0.85 MEN1 (0.37) TAS1R3TAS1R1TAS1R2MAPTDHODH
SCHEMBL1490205 0.84 MEN1 (0.44) TAS1R3TAS1R1TAS1R2POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 — — US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 — — US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 TAS1R3 3820/4885TAS1R1 3836/4885TAS1R2 3547/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 TAS1R3 3820/4885TAS1R1 3836/4885TAS1R2 3547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback